Highly Tough and Biodegradable Poly(ethylene glycol)‐Based Bioadhesives for Large‐Scaled Liver Injury Hemostasis and Tissue Regeneration
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202301086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Yiqian Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Biosis Healing Biological Technology Co., Ltd, Beijing, 102600, China. Hauptthemen laut MEDLINE: Polyethylene Glycols, Tissue Adhesives. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Conventional tissue adhesives face challenges for hemostasis and tissue regeneration in large‐scaled hemorrhage and capillary hypobaric bleeding due to weak adhesion, and inability to degrade at specific sites. Herein, convenient and injectable poly(ethylene glycol) (PEG)‐based adhesives are developed to address the issues for liver hemostasis. The PEG‐bioadhesives are composed of tetra‐armed PEG succinimide glutarate (PEG‐SG), tetra‐armed PEG amine (PEG‐NH 2 ), and tri‐lysine. By mixing the components, the PEG‐bioadhesives can be rapidly formulated for use of liver bleeding closure in hepatectomy. The PEG‐bioadhesives also possess mechanical compliance to native tissues (elastic modulus ≈40 kPa) and tough tissue adhesion (≈28 kPa), which enables sufficient adhering to the injured tissues and promotes liver regeneration with the PEG‐bioadhesive degradation. In both rats of liver injury and pigs of large‐scaled hepatic hemorrhage, the PEG‐bioadhesives show effective hemostasis with superior blood loss than conventional tissue adhesives. Due to biocompatibility and degradability, the PEG‐bioadhesive is advantageous for liver regeneration, while commercial adhesives (e.g., N ‐octyl cyanoacrylate) display adhesion failure and limited liver reconstructions. These PEG‐bioadhesive components are FDA‐approved, and demonstrate excellent adhesion to various tissues not only for liver hemostasis, it is a promising candidate in biomedical translations and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Biosis Healing Biological Technology Co., Ltd, Beijing, 102600, China.
- Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, China.
ORCID-Profile: Yiqian Huang
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Huang, Y., Jing, W., Zeng, J., Xue, Y., Zhang, Y., Yu, X., Wei, P., Zhao, B., & Dong, J. (2023). Highly Tough and Biodegradable Poly(ethylene glycol)‐Based Bioadhesives for Large‐Scaled Liver Injury Hemostasis and Tissue Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301086
Vancouver
Huang Y, Jing W, Zeng J, Xue Y, Zhang Y, Yu X, et al. Highly Tough and Biodegradable Poly(ethylene glycol)‐Based Bioadhesives for Large‐Scaled Liver Injury Hemostasis and Tissue Regeneration. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301086
BibTeX
@article{Huang2023,
author = {Huang, Yiqian and Jing, Wei and Zeng, Jianping and Xue, Yunxia and Zhang, Yan and Yu, Xueqiao and Wei, Pengfei and Zhao, Bo and Dong, Jiahong},
title = {Highly Tough and Biodegradable Poly(ethylene glycol)‐Based Bioadhesives for Large‐Scaled Liver Injury Hemostasis and Tissue Regeneration},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202301086}
}
EUVIMED